Companies / Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

Nasdaq: ARQTCIK 1787306WESTLAKE VILLAGE, CA

Financials · FY2025

Revenue$376.07M
Net income$-16.14M
Total debt$108.90M
Cash$34.12M
Diluted EPS$-0.13
Shares outstanding125.7M

Ownership

125.7M shares outstanding · as of Jul 31, 2026
1.1%Insiders
Ownership
Insiders1.12%1,411,051
10%+ / strategic15.64%19,660,772
Institutions96.32%121,066,406
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Watanabe ToddSee Remarks · Director
0.63%785,957
Edwards Larry ToddSee Remarks
0.14%175,178
Matsuda MasaruSee Remarks
0.11%136,932
Burnett PatrickSee Remarks
0.10%121,150
Vairavan LathaSVP Chief Financial Officer
0.07%87,754
Welgus Howard G.Director
0.04%49,744
Heron Patrick JDirector
0.03%32,213
Leonard Keith RDirector
0.02%22,123

Institutional holders 291

View all →
HolderValue% of shares
Suvretta Capital Management, LLC$347.43M9.52%
Frazier Life Sciences Management, L.P.$286.76M7.86%
BlackRock, Inc.$276.50M8.39%
Rubric Capital Management LP$240.21M6.58%
Vanguard Group Inc$210.65M5.77%
Jennison Associates LLC$196.25M5.38%
Polar Capital Holdings Plc$161.35M4.42%
State Street Corporation$152.67M4.63%
Gilder Gagnon Howe & Co LLC$129.34M3.54%
Morgan Stanley$126.04M3.45%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 2, 2026Leonard Keith R
Director
SellCommon Stock$997.2K-39K
-63.97%
22,123
0.02% of shares
medium
Mar 2, 2026Watanabe Todd
Executive
SellCommon Stock$912.9K-36K
-4.41%
787,025
0.63% of shares
medium
Feb 2, 2026Watanabe Todd
Executive
SellCommon Stock$505.7K-20K
-2.68%
721,306
0.57% of shares
medium
Feb 2, 2026Matsuda Masaru
Executive
SellCommon Stock$489.1K-19K
-14.45%
114,717
0.09% of shares
medium
Jan 2, 2026Welgus Howard G.
Director
SellCommon Stock$289.6K-10K
-12.54%
69,744
0.06% of shares
medium
Mar 2, 2026Welgus Howard G.
Director
SellCommon Stock$256.5K-10K
-16.74%
49,744
0.04% of shares
medium
Feb 4, 2026Burnett Patrick
Executive
SellCommon Stock$252.7K-10K
-10.83%
80,651
0.06% of shares
medium
Feb 2, 2026Welgus Howard G.
Director
SellCommon Stock$250.5K-10K
-14.34%
59,744
0.05% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
State Street CorporationPassive13G—5,822,840—
Prudential Financial IncPassive13G/A—7,079,926—
Rubric Capital Management LPPassive13G/A———
Jennison Associates LLCPassive13G/A—6,758,006—
Prudential Financial IncPassive13G/A—5,302,713—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ARQT——03969K108—